| UniProt ID | CASP7_HUMAN | |
|---|---|---|
| UniProt AC | P55210 | |
| Protein Name | Caspase-7 | |
| Gene Name | CASP7 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 303 | |
| Subcellular Localization | Cytoplasm. | |
| Protein Description | Involved in the activation cascade of caspases responsible for apoptosis execution. Cleaves and activates sterol regulatory element binding proteins (SREBPs). Proteolytically cleaves poly(ADP-ribose) polymerase (PARP) at a '216-Asp-|-Gly-217' bond. Overexpression promotes programmed cell death.. | |
| Protein Sequence | MADDQGCIEEQGVEDSANEDSVDAKPDRSSFVPSLFSKKKKNVTMRSIKTTRDRVPTYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQADSGPINDTDANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MADDQGCIE ------CCCCCCCCC | 29.14 | 22223895 | |
| 16 | Phosphorylation | EEQGVEDSANEDSVD CCCCCCCCCCCCCCC | 21.35 | 29255136 | |
| 21 | Phosphorylation | EDSANEDSVDAKPDR CCCCCCCCCCCCCCH | 18.73 | 22167270 | |
| 29 | Phosphorylation | VDAKPDRSSFVPSLF CCCCCCHHHCHHHHC | 35.19 | 25159151 | |
| 30 | Phosphorylation | DAKPDRSSFVPSLFS CCCCCHHHCHHHHCC | 31.02 | 21815630 | |
| 34 | Phosphorylation | DRSSFVPSLFSKKKK CHHHCHHHHCCCCCC | 36.42 | 22617229 | |
| 37 | Phosphorylation | SFVPSLFSKKKKNVT HCHHHHCCCCCCCCE | 49.19 | 28355574 | |
| 38 | Acetylation | FVPSLFSKKKKNVTM CHHHHCCCCCCCCEE | 62.37 | 25953088 | |
| 38 | Ubiquitination | FVPSLFSKKKKNVTM CHHHHCCCCCCCCEE | 62.37 | - | |
| 38 | Methylation | FVPSLFSKKKKNVTM CHHHHCCCCCCCCEE | 62.37 | - | |
| 38 (in isoform 2) | Ubiquitination | - | 62.37 | - | |
| 39 | Ubiquitination | VPSLFSKKKKNVTMR HHHHCCCCCCCCEEC | 68.71 | - | |
| 39 (in isoform 2) | Ubiquitination | - | 68.71 | - | |
| 44 | Phosphorylation | SKKKKNVTMRSIKTT CCCCCCCEECCEECC | 19.09 | 29514088 | |
| 47 | Phosphorylation | KKNVTMRSIKTTRDR CCCCEECCEECCHHC | 20.02 | 25159151 | |
| 50 | Phosphorylation | VTMRSIKTTRDRVPT CEECCEECCHHCCCC | 25.95 | 23909892 | |
| 51 | Phosphorylation | TMRSIKTTRDRVPTY EECCEECCHHCCCCE | 26.10 | 23909892 | |
| 58 | Phosphorylation | TRDRVPTYQYNMNFE CHHCCCCEECCCCHH | 11.70 | 20068231 | |
| 60 | Phosphorylation | DRVPTYQYNMNFEKL HCCCCEECCCCHHHC | 13.13 | 20068231 | |
| 69 | Ubiquitination | MNFEKLGKCIIINNK CCHHHCCCEEEECCC | 32.47 | - | |
| 70 (in isoform 3) | Phosphorylation | - | 2.28 | 27251275 | |
| 80 | Acetylation | INNKNFDKVTGMGVR ECCCCCCCCCCCCCC | 37.24 | 25953088 | |
| 80 (in isoform 2) | Ubiquitination | - | 37.24 | - | |
| 80 | Ubiquitination | INNKNFDKVTGMGVR ECCCCCCCCCCCCCC | 37.24 | - | |
| 92 | Ubiquitination | GVRNGTDKDAEALFK CCCCCCHHHHHHHHH | 59.69 | - | |
| 99 | Ubiquitination | KDAEALFKCFRSLGF HHHHHHHHHHHHCCC | 33.06 | - | |
| 125 (in isoform 2) | Ubiquitination | - | 58.05 | - | |
| 125 | Ubiquitination | KMQDLLKKASEEDHT HHHHHHHHHCCCCHH | 58.05 | - | |
| 132 | Phosphorylation | KASEEDHTNAACFAC HHCCCCHHHHHHHHH | 38.58 | 27251275 | |
| 132 (in isoform 3) | Ubiquitination | - | 38.58 | - | |
| 153 | Ubiquitination | EENVIYGKDGVTPIK CCCEEECCCCCCCHH | 34.05 | - | |
| 157 | Phosphorylation | IYGKDGVTPIKDLTA EECCCCCCCHHHHHH | 25.48 | 21815630 | |
| 160 | Ubiquitination | KDGVTPIKDLTAHFR CCCCCCHHHHHHHHC | 48.14 | - | |
| 160 | Acetylation | KDGVTPIKDLTAHFR CCCCCCHHHHHHHHC | 48.14 | 25953088 | |
| 172 | Ubiquitination | HFRGDRCKTLLEKPK HHCCHHHHHHHHCCC | 43.00 | - | |
| 173 | Phosphorylation | FRGDRCKTLLEKPKL HCCHHHHHHHHCCCE | 39.95 | 21555521 | |
| 177 | Ubiquitination | RCKTLLEKPKLFFIQ HHHHHHHCCCEEEEE | 47.63 | - | |
| 193 (in isoform 2) | Phosphorylation | - | 69.58 | - | |
| 193 (in isoform 3) | Ubiquitination | - | 69.58 | - | |
| 199 | Phosphorylation | DDGIQADSGPINDTD CCCCCCCCCCCCCCC | 49.86 | 28348404 | |
| 200 (in isoform 2) | Phosphorylation | - | 27.88 | - | |
| 205 (in isoform 3) | Ubiquitination | - | 32.30 | - | |
| 234 | Phosphorylation | PGYYSWRSPGRGSWF CCCCCCCCCCCCHHH | 26.00 | 25159151 | |
| 239 | Phosphorylation | WRSPGRGSWFVQALC CCCCCCCHHHHHHHH | 18.91 | 21555521 | |
| 286 | Ubiquitination | DPHFHEKKQIPCVVS CCCCCHHCHHCHHHH | 50.94 | - | |
| 319 | Phosphorylation | ----------------------- ----------------------- | 27251275 | ||
| 319 (in isoform 3) | Ubiquitination | - | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 30 | S | Phosphorylation | Kinase | PAK2 | Q13177 | PSP |
| 173 | T | Phosphorylation | Kinase | PAK2 | Q13177 | PSP |
| 239 | S | Phosphorylation | Kinase | PAK2 | Q13177 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | BIRC2 | Q13490 | PMID:22199232 |
| - | K | Ubiquitination | E3 ubiquitin ligase | BIRC3 | Q13489 | PMID:22199232 |
| - | K | Ubiquitination | E3 ubiquitin ligase | XIAP | P98170 | PMID:22199232 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CASP7_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CASP7_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-16, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-16, AND MASS SPECTROMETRY. | |